-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday
Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday
U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday.
Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) rose sharply during Thursday's session.
Enliven Therapeutics announced proof of concept data from Phase 1 clinical trial of ELVN-001 in chronic myeloid leukemia.
Enliven Therapeutics shares surged 26% to $24.97 on Thursday.
Here are some other big stocks recording losses in today's session.
- Rallybio Corporation (NASDAQ:RLYB) shares gained 89.6% to $3.09 after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT.
- Alpine Immune Sciences, Inc. (NASDAQ:ALPN) jumped 36.6% to $64.25 after Vertex entered into an agreement to acquire the company.
- Janux Therapeutics, Inc. (NASDAQ:JANX) shares jumped 16.8% to $52.15 following Wednesday reports suggesting the company is said to weigh a possible sale.
- Gyre Therapeutics, Inc. (NASDAQ:GYRE) rose 14.6% to $15.91.
- AnaptysBio, Inc. (NASDAQ:ANAB) rose 11.4% to $24.72. Wells Fargo analyst Derek Archila initiated coverage on AnaptysBio with an Overweight rating and announced a price target of $56.
- Fiverr International Ltd. (NYSE:FVRR) gained 10.5% to $21.25 after the company's board authorized a $100 million share repurchase program.
- GigaCloud Technology Inc. (NASDAQ:GCT) shares jumped 10.2% to $34.18.
- Nurix Therapeutics, Inc. (NASDAQ:NRIX) climbed 9.6% to $17.21. Baird analyst Joel Beatty maintained Nurix Therapeutics with an Outperform and raised the price target from $24 to $25.
- AlTi Global, Inc. (NASDAQ:ALTI) gained 9.3% to $5.06.
- Nexxen International Ltd. (NASDAQ:NEXN) rose 7.3% to $5.62.
- StepStone Group LP (NASDAQ:STEP) gained 7.1% to $37.46 after JP Morgan upgraded the stock from Neutral to Overweight.
- Frontline plc (NYSE:FRO) rose 5.9% to $24.47.
- IAMGOLD Corporation (NYSE:IAG) gained 3.6% to $3.74.
Now Read This: Dell, Designer Brands And 2 Other Stocks Insiders Are Selling
U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday.
美国股市涨跌互现,道琼斯指数周四下跌超过50点。
Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) rose sharply during Thursday's session.
Enliven Therapeutics, Inc.(纳斯达克股票代码:ELVN)的股价在周四的交易中大幅上涨。
Enliven Therapeutics announced proof of concept data from Phase 1 clinical trial of ELVN-001 in chronic myeloid leukemia.
Enliven Therapeutics 公布了慢性髓系白血病的 ELVN-001 一期临床试验的概念验证数据。
Enliven Therapeutics shares surged 26% to $24.97 on Thursday.
周四,Enliven Therapeutics股价飙升26%,至24.97美元。
Here are some other big stocks recording losses in today's session.
以下是今天交易日其他一些录得跌幅的大型股票。
- Rallybio Corporation (NASDAQ:RLYB) shares gained 89.6% to $3.09 after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT.
- Alpine Immune Sciences, Inc. (NASDAQ:ALPN) jumped 36.6% to $64.25 after Vertex entered into an agreement to acquire the company.
- Janux Therapeutics, Inc. (NASDAQ:JANX) shares jumped 16.8% to $52.15 following Wednesday reports suggesting the company is said to weigh a possible sale.
- Gyre Therapeutics, Inc. (NASDAQ:GYRE) rose 14.6% to $15.91.
- AnaptysBio, Inc. (NASDAQ:ANAB) rose 11.4% to $24.72. Wells Fargo analyst Derek Archila initiated coverage on AnaptysBio with an Overweight rating and announced a price target of $56.
- Fiverr International Ltd. (NYSE:FVRR) gained 10.5% to $21.25 after the company's board authorized a $100 million share repurchase program.
- GigaCloud Technology Inc. (NASDAQ:GCT) shares jumped 10.2% to $34.18.
- Nurix Therapeutics, Inc. (NASDAQ:NRIX) climbed 9.6% to $17.21. Baird analyst Joel Beatty maintained Nurix Therapeutics with an Outperform and raised the price target from $24 to $25.
- AlTi Global, Inc. (NASDAQ:ALTI) gained 9.3% to $5.06.
- Nexxen International Ltd. (NASDAQ:NEXN) rose 7.3% to $5.62.
- StepStone Group LP (NASDAQ:STEP) gained 7.1% to $37.46 after JP Morgan upgraded the stock from Neutral to Overweight.
- Frontline plc (NYSE:FRO) rose 5.9% to $24.47.
- IAMGOLD Corporation (NYSE:IAG) gained 3.6% to $3.74.
- Rallybio Corporation(纳斯达克股票代码:RLYB)股价上涨89.6%,至3.09美元,此前该公司宣布与强生公司合作,为面临FNAIT风险的孕妇推进治疗方案。
- 在Vertex签订收购阿尔卑斯免疫科学公司(纳斯达克股票代码:ALPN)的协议后,该公司上涨36.6%,至64.25美元。
- Janux Therapeutics, Inc.(纳斯达克股票代码:JANX)股价上涨16.8%,至52.15美元,此前周三有报道称该公司正在权衡可能的出售。
- Gyre Therapeutics, Inc.(纳斯达克股票代码:GYRE)上涨14.6%,至15.91美元。
- AnaptysBio, Inc.(纳斯达克股票代码:ANAB)上涨11.4%,至24.72美元。富国银行分析师德里克·阿奇拉以增持评级启动了对AnaptysBio的报道,并宣布目标股价为56美元。
- Fiverr International Ltd.(纽约证券交易所代码:FVRR)上涨10.5%,至21.25美元,此前该公司董事会批准了一项1亿美元的股票回购计划。
- GigaCloud Technology Inc.(纳斯达克股票代码:GCT)股价上涨10.2%,至34.18美元。
- Nurix Therapeutics, Inc.(纳斯达克股票代码:NRIX)上涨9.6%,至17.21美元。贝尔德分析师乔尔·比蒂维持Nurix Therapeutics的跑赢大盘,并将目标股价从24美元上调至25美元。
- ALTi Global, Inc.(纳斯达克股票代码:ALTI)上涨9.3%,至5.06美元。
- 耐克森国际有限公司(纳斯达克股票代码:NEXN)上涨7.3%,至5.62美元。
- 摩根大通将股票从中性上调至增持后,StepStone Group LP(纳斯达克股票代码:STEP)上涨7.1%,至37.46美元。
- Frontline plc(纽约证券交易所代码:FRO)上涨5.9%,至24.47美元。
- IAMGOLD Corporation(纽约证券交易所代码:IAG)上涨3.6%,至3.74美元。
Now Read This: Dell, Designer Brands And 2 Other Stocks Insiders Are Selling
现在读这个: 戴尔、设计师品牌和其他两只股票内部人士正在抛售
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧